Cite
HARVARD Citation
Brooks, B. et al. (2022). Evidence for generalizability of edaravone efficacy using a novel machine learning risk-based subgroup analysis tool. Amyotrophic lateral sclerosis and frontotemporal degeneration. 23 (1), pp. 49-57. [Online].